✦ LIBER ✦

Cost-effectiveness of dabigatran etexilate for the prevention of stroke and systemic embolism in atrial fibrillation:A Canadian payer perspective

✍ Scribed by Sorensen, S. V.; Kansal, A. R.; Connolly, S.; Peng, S.; Linnehan, J.; Bradley-Kennedy, C.; Plumb, J. M.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost-effectiveness of dabigatran etexila

✍ Chang, Chia-Hsien; Yang, Yea-Huei Kao; Chen, Jyh-Hong; Lin, Li-Jen 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 570 KB

PCV59 Cost-Effectiveness of Dabigatran E

✍ Y.B. Belousov; V.Y. Mareev; D.Y. Belousov; E.V. Afanasieva; Y.I. Ashikhmin; A.V. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

Spotlight on Dabigatran Etexilate in the

✍ Karly P. Garnock-Jones 📂 Article 📅 2011 🏛 Springer International Publishing AG 🌐 English ⚖ 130 KB

PCV60 Cost Effectiveness of Dabigatran E

✍ S. Kececioglu; P. Ulus; F. Cukadar 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

Cost-effectiveness of dabigatran versus

✍ Chevalier, Julie; Delaitre, Olivier; Hammès, Florence; de Pouvourville, Gérard 📂 Article 📅 2014 🏛 Elsevier 🌐 English ⚖ 943 KB

Baseline characteristics of elderly pati

✍ A. Vilches-Moraga; L. Garrido-González; C. Rodriguez-Pascual; E. Paredes-Galán; 📂 Article 📅 2012 🏛 Elsevier 🌐 English ⚖ 77 KB